KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Asset Writedowns and Impairment (2021 - 2023)

CareDx (CDNA) has disclosed Asset Writedowns and Impairment for 3 consecutive years, with -$1.0 million as the latest value for Q4 2023.

  • Quarterly Asset Writedowns and Impairment changed N/A to -$1.0 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Sep 2024, down 200.0% year-over-year, with the annual reading at $2.3 million for FY2025, N/A changed from the prior year.
  • Asset Writedowns and Impairment hit -$1.0 million in Q4 2023 for CareDx, down from $1.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.4 million in Q4 2021 to a low of -$1.0 million in Q4 2023.
  • Historically, Asset Writedowns and Impairment has averaged $819250.0 across 3 years, with a median of $920000.0 in 2022.